Molecular and Epidemiologic Findings of Childhood Acute Leukemia in Costa Rica
Authors:
- Carlos Santamaría-QuesadaCSCarlos Santamaría-Quesada
- Mario VargasMVMario Vargas
- Patricia VenegasPVPatricia Venegas
- Melvin CalvoMCMelvin Calvo
- Catalina ObandoCOCatalina Obando
- Berta ValverdeBVBerta Valverde
- Walter CartínWCWalter Cartín
- Juan Manuel CarrilloJCJuan Manuel Carrillo
- Rafael JimenezRJRafael Jimenez
- Marcos GonzálezMGMarcos González
- 1 February 2009
- journal article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 31 (2) , 131-135
Abstract
In Central America, nearly 70% of pediatric cancer is related to hemato-oncologic disorders, especially acute lymphoblastic leukemia (ALL). Preliminary studies have described a high incidence of childhood leukemia in these countries; however, no molecular analyses of these malignancies have yet been carried out. We studied diagnostic samples from 84 patients from the National Children's Hospital in San Jose, Costa Rica (65 precursor B-ALL, 5 T-cell ALL, and 14 acute myeloblastic leukemia). Our methodology included cytogenetic, fluorescent in situ hybridization, and polymerase chain reaction approaches. The observed rate of leukemia was 52.2 cases per million children per year. Twelve out of 65 (18.4%) precursor B-ALL tested positive for TEL-AML1 and 3 cases for BCR-ABL (4.6%). In addition, we detected 2 patients carrying an E2A-PBX1 transcript (3.1%) and 1 patient with an MLL-AF4 fusion gene (1.5%). None of the T-cell ALL cases were positive for either SIL-TAL1 or HOX11L2. Within 14 acute myeloblastic leukemia patients, we confirmed 2 cases with FLT3-internal tandem duplication+, 1 patient with AML1-ETO, and only 1 case carrying a PML-RARalpha rearrangement. The present study confirms the relatively high incidence of pediatric leukemia in Costa Rica and constitutes the first report regarding the incidence of the main molecular alterations of childhood leukemia in our region.Keywords
This publication has 26 references indexed in Scilit:
- Childhood cancer epidemiology in low‐income countriesCancer, 2007
- Clinical implications of FLT3 mutations in pediatric AMLBlood, 2006
- Clinical epidemiology of childhood cancer in Central America and Caribbean countriesAnnals of Oncology, 2004
- Childhood leukaemia in Costa Rica, 1981–96Paediatric and Perinatal Epidemiology, 2002
- Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2000
- TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensificationLeukemia, 1999
- Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia.Journal of Clinical Oncology, 1998
- North-South twinning in paediatric haemato-oncology: the La Mascota programme, NicaraguaThe Lancet, 1998
- Incidence and Clinical Relevance of TEL/AML1 Fusion Genes in Children With Acute Lymphoblastic Leukemia Enrolled in the German and Italian Multicenter Therapy TrialsBlood, 1997
- The international incidence of childhood cancerInternational Journal of Cancer, 1988